Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: GST who wrote (106292)	7/19/2000 1:11:42 PM
From: ALTERN8	Respond to of 164684

Bot some AMZN just now, looking for a nice bounce this week and into earnings next week.

To: GST who wrote (106292)	7/19/2000 5:53:52 PM
From: H James Morris	Read Replies (2) \| Respond to of 164684

Gst, what bear market are you referring to? >San Carlos, California, July 19 (Bloomberg) -- Argonaut Technologies Inc., whose laboratory instruments and software help drug and biotech companies' chemists discover new products, rose in its first day of trading. Argonaut shares rose 8 7/16, or 56 percent, to 23 7/16 in Nasdaq Stock Market trading of 7.22 million. The company sells testing and synthesizing equipment to drug and biotech companies seeking to develop drugs using new genetic information. Enthusiasm for genetic research-related companies helped boost shares of Transgenomic Inc. and DeCode Genetics Inc. which began trading yesterday. ``It's like the California Gold Rush of 1849 -- the people who sold the picks and shovels made the money,'' said John Fitzgibbon, IPO editor at WorldFinanceNet.com, which researches initial offerings. ``The Nasdaq came back to life, and biotech issues were part of the hot crowd.'' Argonaut, based south of San Francisco in San Carlos, California, last night sold 4.6 million shares, 15 percent more than planned, at $15 a share through UBS Warburg LLC. Argonaut's net loss totaled $2 million in the three months ended March 31, compared with a net loss of $1.4 million in the same period one year earlier. Net sales rose to about $3.6 million from almost $3 million. Top customers include Pfizer Inc., Abbott Laboratories Inc., Pharmacia Corp. and Aventis SA. PE Corp.'s PE Biosystems unit and Mettler-Toledo AG are Argonaut's main competition, the company said in government filings. PE's shares have nearly tripled over the past 12 months, while Switzerland-based Mettler-Toledo's shares are up 28 percent. Also today, Support.com Inc. shares more than doubled, rising 18 5/8 to 32 5/8 after selling 4.25 million shares at $14. The company provides technical support for businesses like Bear Stearns Cos. and Cisco Systems Inc. Investors have been more enthusiastic over IPOs lately, following a 57 percent decline in the Bloomberg IPO Index between March 1 and May 26. Since then, the index has gained 52 percent. Jul/19/2000 16:19 ET